| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/27/1997 | WO1997000965A3 A lipidic vector for nucleic acid delivery |
| 02/27/1997 | WO1996040885A3 β-SECRETASE, ANTIBODIES TO β-SECRETASE, AND ASSAYS FOR DETECTING β-SECRETASE INHIBITION |
| 02/27/1997 | DE19628882A1 Enzyme for oxidn. of L-galactono-gamma-lactone to ascorbic acid |
| 02/27/1997 | DE19548301C1 Inhibiting signal mols. involved in plant-microbial pathogen interaction |
| 02/27/1997 | DE19531033A1 Antikörper gegen an Oberflächen von Carcinom-Zellen außerhalb von Desmosomen exponierte Epitope desmosomaler Cadherine Antibodies against at surfaces of carcinoma cells outside exposed epitopes of desmosomal cadherins of desmosomes |
| 02/27/1997 | DE19530816A1 Verwendung von mutierter Subtilisin-Protease in kosmetischen Produkten Use of mutated subtilisin protease in cosmetic products |
| 02/27/1997 | CA2230195A1 A method to increase the density of antigen on antigen presenting cells |
| 02/27/1997 | CA2230051A1 Deuteriated substances |
| 02/27/1997 | CA2229938A1 Methods of assessing mhc class i expression and proteins capable of modulating class i expression |
| 02/27/1997 | CA2229847A1 High efficiency retroviral packaging system |
| 02/27/1997 | CA2229605A1 Genes and proteins controlling cholesterol synthesis |
| 02/27/1997 | CA2229595A1 Method for treatment of cancer and infectious diseases and compositions useful in same |
| 02/27/1997 | CA2229557A1 Binding of osteogenic protein-i (op-1) and analogs thereof to the cell surface receptor alk-1 and analogs thereof |
| 02/27/1997 | CA2229543A1 Heat shock protein-based vaccines and immunotherapies |
| 02/27/1997 | CA2229540A1 Epitope tagging system |
| 02/27/1997 | CA2229488A1 Novel glycerol phosphatase with stereo-specific activity |
| 02/27/1997 | CA2229287A1 Regulation of cellular functions by ectopic expression of non-endogenous cell signalling receptors |
| 02/27/1997 | CA2229226A1 All-in-one nucleic acid amplification assay |
| 02/27/1997 | CA2229208A1 Dna sequences and secreted proteins encoded thereby |
| 02/27/1997 | CA2229168A1 Methods and materials for producing pathogen-resistant plants |
| 02/27/1997 | CA2229143A1 Reagents and methods useful for controlling the translation of hepatitis gbv proteins |
| 02/27/1997 | CA2229142A1 Nucleic acid detection of hepatitis gb virus |
| 02/27/1997 | CA2229126A1 Opioid antagonists and methods of their use |
| 02/27/1997 | CA2229061A1 Transgenic plant cells and plants with an increased glycolysis rate |
| 02/27/1997 | CA2228965A1 Control of cd44 gene expression for therapeutic use |
| 02/27/1997 | CA2228159A1 Self-deleting vectors for gene therapy |
| 02/27/1997 | CA2227414A1 Plant gene encoding acetyl coenzyme a carboxylase biotin carboxylase carrier protein |
| 02/27/1997 | CA2227174A1 Traf inhibitors |
| 02/27/1997 | CA2226299A1 Hyper comb-branched polymer conjugates |
| 02/27/1997 | CA2202928A1 Poly(organo)phosphazenes for use in synthetic transfection systems |
| 02/26/1997 | EP0759476A1 Method of detecting human cytochrome p4502d6 gene polymorphism |
| 02/26/1997 | EP0759474A2 A regulatory factor involved in expression of nitrilase gene, and its gene |
| 02/26/1997 | EP0759473A1 Deleted Lysostaphingene of Staphylococcus simulans |
| 02/26/1997 | EP0759472A1 Process for producing trans-4-hydroxy-l-proline |
| 02/26/1997 | EP0759471A1 Recombinant human immunodeficiency virus vector and process for producing the same |
| 02/26/1997 | EP0759470A2 Gene encoding endoglycoceramidase activator |
| 02/26/1997 | EP0759469A1 Bacteriocin |
| 02/26/1997 | EP0759468A1 Feline interleukin-4 |
| 02/26/1997 | EP0759467A2 Hepatocyte growth factor activator inhibitor |
| 02/26/1997 | EP0759466A2 Low binding affinity interleukin-12 beta receptors |
| 02/26/1997 | EP0759465A1 Gene imparting flocculability to yeast and gene product |
| 02/26/1997 | EP0759170A1 Uses of green fluorescent protein |
| 02/26/1997 | EP0759091A1 MATERIALS AND METHODS FOR THE DETECTION OF $i(MYCOBACTERIUM TUBERCULOSIS) |
| 02/26/1997 | EP0759087A1 Compositions and methods for targeting gene delivery vehicles |
| 02/26/1997 | EP0759086A1 Method of introducing pathogen resistance in plants |
| 02/26/1997 | EP0759085A1 Chimeric genes comprising a fungus-responsive element |
| 02/26/1997 | EP0759084A1 Complex inducible promoter system derivable from a phage of a lactic acid bacterium (lab), and its use in a lab for production of a desired protein |
| 02/26/1997 | EP0759083A1 Methods of inducing gene expression by ionizing radiation |
| 02/26/1997 | EP0759082A1 Dna construct for effecting homologous recombination and uses thereof |
| 02/26/1997 | EP0759081A1 Glucan-binding proteins, and use thereof |
| 02/26/1997 | EP0759080A1 Nucleic acid fragments, chimeric genes and methods for increasing the methionine content of the seeds of plants |
| 02/26/1997 | EP0759079A1 DNA ENCODING PRECURSOR OF INTERLEUKIN-1$g(b) CONVERTING ENZYME-RELATED CYSTEINE PROTEINASE III (ICE rel?-III) |
| 02/26/1997 | EP0759078A1 Genes for the synthesis of antipathogenic substances |
| 02/26/1997 | EP0759077A1 Lanthionine-containing antimicrobial compound |
| 02/26/1997 | EP0759076A1 GENES REGULATING THE RESPONSE OF $i(ZEA MAYS) TO WATER DEFICIT |
| 02/26/1997 | EP0759075A1 Apoptosis regulating gene |
| 02/26/1997 | EP0759073A1 AN ENZYME WITH ENDO-1,3(4)-$g(b)-GLUCANASE ACTIVITY |
| 02/26/1997 | EP0759072A1 Poxvirus-canine distemper virus (cdv) recombinants and compositions and methods employing the recombinants |
| 02/26/1997 | EP0759070A1 Blood-borne mesenchymal cells |
| 02/26/1997 | EP0759068A1 $i(RPS2) GENE AND USES THEREOF |
| 02/26/1997 | EP0759067A1 Transforming growth factor alpha h1 |
| 02/26/1997 | EP0759036A1 Immunointeractive molecules-i |
| 02/26/1997 | EP0759033A1 CLONING OF NON-IgA Fc BINDING FORMS OF THE GROUP B STREPTOCOCCAL BETA ANTIGENS |
| 02/26/1997 | EP0759028A1 Method of detecting prions in a sample and transgenic animal used for same |
| 02/26/1997 | EP0758904A1 Methods and compositions for the treatment of glomerulonephritis and other inflammatory diseases |
| 02/26/1997 | EP0758841A1 Cotton modification using ovary-tissue transcriptional factors |
| 02/26/1997 | EP0659045A4 Genetically engineered mice containing alterations in the genes encoding retinoic acid receptor proteins. |
| 02/26/1997 | EP0656059A4 Purified chitinases and use thereof. |
| 02/26/1997 | EP0651824A4 Transcription control element for increasing gene expression in myoblasts. |
| 02/26/1997 | EP0596887A4 Genetically engineered mice containing alterations in the mhc class ii genes. |
| 02/26/1997 | EP0570554A4 Monoclonal antibody and antibody components elicited to a polypeptide antigen ground state |
| 02/26/1997 | EP0552267B1 Engineered bacteriophages and vaccines containing them |
| 02/26/1997 | EP0541753B1 NOVEL HYBRID, SOLUBLE AND UNCLEAVED gp160 VARIANT |
| 02/26/1997 | EP0437537B1 Bacterial detection by phage transduction of detectable phenotype |
| 02/26/1997 | EP0426768B1 Expression of a DNA sequence derived from a Nocardioform microorganism and encoding a cholesterol oxidase in a host Streptomyces microorganism |
| 02/26/1997 | CN1143979A Electrochemical denaturation of double-stranded nucleic acid |
| 02/26/1997 | CN1143978A Antimicrobial proteins from aralia and impatiens |
| 02/26/1997 | CN1143977A Method for screening unknown organisms |
| 02/26/1997 | CN1143969A Compositions and methods using unbound mpl receptor for stimulating platelet production |
| 02/26/1997 | CN1143967A Method for variation of chromatin condensation |
| 02/26/1997 | CN1143917A Mesoscale sample preparation device and system for determination and processing of analytes |
| 02/26/1997 | CN1143894A Macrophage inflammatory proteins-3,-4 and -1 r |
| 02/26/1997 | CN1143678A Gene encoding lacto-N-biosidase |
| 02/26/1997 | CN1143677A High-butanol ratio clostridium acetobutylicium and culturing method and use thereof |
| 02/25/1997 | US5606047 Includes polynucleotide duplexes that have significant binding activity for lupus antibodies |
| 02/25/1997 | US5606046 Contacting dna suspension with glass fiber membrane which has been treated with trifluoroacetic acid to bind dna, washing, eluting |
| 02/25/1997 | US5606044 Using nucleic acid probes |
| 02/25/1997 | US5606043 Methods for the diagnosis of glaucoma |
| 02/25/1997 | US5606042 Dna sequence |
| 02/25/1997 | US5606032 Extraction of vertebrate brain material to obtain protein; chromatographic purification |
| 02/25/1997 | US5606031 Expressing gene coding for neurotrophic factor in bacteria, solubilizing, sulfonylating, isolating and purifying by anion exchange chromatography, allowing to refold, purifying by cation exchange chromatography |
| 02/25/1997 | US5606024 Canine G-CSF polypeptides and pharmaceutical compositions comprising same |
| 02/25/1997 | US5606023 Reduced toxicity |
| 02/25/1997 | US5606022 Cloning and identification of a two component signal transducing regulatory system from Bacteroides fragilis |
| 02/25/1997 | US5606021 Mineralocorticoid receptor compositions and methods |
| 02/25/1997 | US5606019 Synthetic proteins having alternating blocks of fibroin and elastin repeating units; bioresorbable |
| 02/25/1997 | US5605886 Anti-obesity proteins |
| 02/25/1997 | US5605830 Cancer diagnosis, therapy |
| 02/25/1997 | US5605825 Human PAK65 |
| 02/25/1997 | US5605823 Genetic engineered protein |